Cite

HARVARD Citation

    Sekiguchi, Y. et al. (2013). Ambiguous effects of anti-VEGF monoclonal antibody (bevacizumab) for POEMS syndrome. Journal of neurology, neurosurgery and psychiatry. 84 (12), pp. 1346-1348. [Online]. 
  
Back to record